$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Coronavirus Disease 19 and Thyroid Disease
코로나바이러스 감염병-19와 갑상선 질환 원문보기

臨床耳鼻咽喉科 = Journal of clinical otolaryngology, v.32 no.3, 2021년, pp.179 - 188  

Kim, Mijin ,  Kim, Bo Hyun

초록이 없습니다.

참고문헌 (76)

  1. 10.1056/NEJMoa2001017 Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. China Novel Coronavirus Investigating and Research Team. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020;382(8):727-33. 10.1056/NEJMoa2001017 31978945 PMC7092803 

  2. 10.3346/jkms.2020.35.e61 Kim JY, Choe PG, Oh Y, Oh KJ, Kim J, Park SJ, et al. The first case of 2019 novel coronavirus pneumonia imported into Korea from Wuhan, China: implication for infection prevention and control measures. J Korean Med Sci 2020;35(5):e61. 10.3346/jkms.2020.35.e61 32030925 PMC7008073 

  3. World Health Organization. Weekly operational update on COVID-19 (16 August 2021) [Internet]. 2021 [cited 2021 Sep 15]. Available from: https://www.who.int/publications/m/item/weekly-operational-update-on-covid-19---16-august-2021 

  4. 10.1007/s15010-020-01401-y Cheng ZJ, Shan J. 2019 Novel coronavirus: where we are and what we know. Infection 2020;48(2):155-63. 10.1007/s15010-020-01401-y 32072569 PMC7095345 

  5. 10.3904/kjm.2020.95.4.232 Shin J. Severe acute respiratory syndrome-coronavirus 2 infection: role of angiotensin-converting enzyme 2. Korean J Med 2020;95(4):232-5. 10.3904/kjm.2020.95.4.232 

  6. 10.1038/nature03712 Imai Y, Kuba K, Rao S, Huan Y, Guo F, Guan B, et al. Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature 2005;436(7047):112-6. 10.1038/nature03712 16001071 PMC7094998 

  7. 10.1016/j.lfs.2020.118142 Zhang J, Wang M, Ding W, Wan J. The interaction of RAAS inhibitors with COVID-19: current progress, perspective and future. Life Sci 2020;257:118142. 10.1016/j.lfs.2020.118142 32712300 PMC7377983 

  8. 10.1371/journal.pone.0248058 Park J, Lee SH, You SC, Kim J, Yang K. Effect of renin-angiotensin-aldosterone system inhibitors on Covid-19 patients in Korea. PLOS ONE 2021;16(3):e0248058. 10.1371/journal.pone.0248058 33705440 PMC7951918 

  9. 10.1161/CIRCULATIONAHA.120.047022 Messerli FH, Siontis GCM, Rexhaj E. COVID-19 and renin angiotensin blockers: current evidence and recommendations. Circulation 2020;141(25):2042-4. 10.1161/CIRCULATIONAHA.120.047022 32282224 PMC7302095 

  10. 10.1007/s12105-020-01212-5 Lechien JR, Radulesco T, Calvo-Henriquez C, Chiesa-Estomba CM, Hans S, Barillari MR, et al. ACE2 & TMPRSS2 expressions in head & neck tissues: a systematic review. Head Neck Pathol 2021;15(1):225-35. 10.1007/s12105-020-01212-5 32816230 PMC7439628 

  11. 10.1007/s11154-020-09615-z Scappaticcio L, Pitoia F, Esposito K, Piccardo A, Trimboli P. Impact of COVID-19 on the thyroid gland: an update. Rev Endocr Metab Disord 2020;1-13. 10.1007/s11154-020-09615-z 33241508 PMC7688298 

  12. 10.1186/s40249-020-00662-x Li MY, Li L, Zhang Y, Wang XS. Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infect Dis Poverty 2020;9(1):45. 10.1186/s40249-020-00662-x 32345362 PMC7186534 

  13. 10.1177/1753944715623228 Diniz GP, Senger N, Carneiro-Ramos MS, Santos RAS, Barreto-Chaves MLM. Cardiac ACE2/angiotensin 1-7/Mas receptor axis is activated in thyroid hormone-induced cardiac hypertrophy. Ther Adv Cardiovasc Dis 2016;10(4):192-202. 10.1177/1753944715623228 26715125 PMC5942623 

  14. 10.1080/07435800.2020.1767127 Davis PJ, Lin HY, Hercbergs A, Keating KA, Mousa SA. Coronaviruses and integrin αvβ3: does thyroid hormone modify the relationship? Endocr Res 2020;45(3):210-5. 10.1080/07435800.2020.1767127 32628899 

  15. 10.1136/bmj.m1091 Chen T, Wu D, Chen H, Yan W, Yang D, Chen G, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ 2020;368:m1091. 10.1136/bmj.m1091 32217556 PMC7190011 

  16. 10.1210/clinem/dgaa537 Brancatella A, Ricci D, Cappellani D, Viola N, Sgro D, Santini F, et al. Is subacute thyroiditis an underestimated manifestation of SARS-CoV-2 infection? Insights from a case series. J Clin Endocrinol Metab 2020;105(10):e3742-6. 10.1210/clinem/dgaa537 32780854 PMC7454668 

  17. 10.3389/fendo.2021.708333 Inaba H, Aizawa T. Coronavirus disease 2019 and the thyroid - progress and perspectives. Front Endocrinol 2021;12: 708333. 10.3389/fendo.2021.708333 34276567 PMC8279745 

  18. 10.1161/01.RES.87.5.e1 Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N, et al. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res 2000;87(5):e1-9. 10.1161/01.RES.87.5.e1 10969042 

  19. 10.1016/j.cell.2020.02.052 Ho?mann M, Kleine-Weber H, Schroeder S, Kruger N, Herrler T, Erichsen S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 2020;181(2):271-80. 10.1016/j.cell.2020.02.052 32142651 PMC7102627 

  20. 10.1016/j.cell.2020.02.058 Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Veesler D. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell 2020;181(2):281-92. 10.1016/j.cell.2020.02.058 32155444 PMC7102599 

  21. 10.1128/JVI.02232-10 Glowacka I, Bertram S, Muller MA, Allen P, Soilleux E, Pfe?erle S, et al. Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response. J Virol 2011;85(9):4122-34. 10.1128/JVI.02232-10 21325420 PMC3126222 

  22. 10.1126/science.abb2507 Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh CL, Abiona O, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science 2020;367(6483): 1260-3. 10.1126/science.abb2507 32075877 PMC7164637 

  23. 10.1016/j.antiviral.2020.104742 Coutard B, Valle C, de Lamballerie X, Canard B, Seidah NG, Decroly E. The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade. Antiviral Res 2020;176:104742. 10.1016/j.antiviral.2020.104742 32057769 PMC7114094 

  24. 10.3390/v12050491 Xiao L, Sakagami H, Miwa N. ACE2: the key molecule for understanding the pathophysiology of severe and critical conditions of COVID-19: demon or angel? Viruses 2020;12(5):491. 10.3390/v12050491 32354022 PMC7290508 

  25. 10.1016/j.virusres.2007.01.022 Guo Y, Korteweg C, McNutt MA, Gu J. Pathogenetic mechanisms of severe acute respiratory syndrome. Virus Res 2008;133(1):4-12. 10.1016/j.virusres.2007.01.022 17825937 PMC7114157 

  26. 10.1016/S0140-6736(20)30183-5 Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395(10223):497-506. 10.1016/S0140-6736(20)30183-5 

  27. 10.3390/ijerph17186630 Gorini F, Bianchi F, Iervasi G. COVID-19 and thyroid: progress and prospects. Int J Environ Res Public Health 2020; 17(18):6630. 10.3390/ijerph17186630 32932954 PMC7559547 

  28. 10.1007/s10238-020-00648-x Gavriatopoulou M, Korompoki E, Fotiou D, Ntanasis-Stathopoulos I, Psaltopoulou T, Kastritis E, et al. Organ-specific manifestations of COVID-19 infection. Clin Exp Med 2020;20(4):493-506. 10.1007/s10238-020-00648-x 32720223 PMC7383117 

  29. 10.1210/endocr/bqaa108 Lazartigues E, Qadir MMF, Mauvais-Jarvis F. Endocrine significance of SARS-CoV-2’s reliance on ACE2. Endocrinology 2020;161(9):bqaa108. 10.1210/endocr/bqaa108 32652001 PMC7454499 

  30. 10.1089/thy.2010.0429 De Vito P, Incerpi S, Pedersen JZ, Luly P, Davis FB, Davis PJ. Thyroid hormones as modulators of immune activities at the cellular level. Thyroid 2011;21(8):879-90. 10.1089/thy.2010.0429 21745103 

  31. 10.1210/edrv-14-1-107 Tomer Y, Davies TF. Infection, thyroid disease, and autoimmunity. Endocr Rev 1993;14(1):107-20. 10.1210/edrv-14-1-107 8491150 

  32. 10.3390/ijerph18010284 Qi J, Zhou Y, Hua J, Zhang L, Bian J, Liu B, et al. The scRNA-seq expression pro?ling of the receptor ACE2 and the cellular protease TMPRSS2 reveals human organs susceptible to SARS-CoV-2 infection. Int J Environ Res Public Health 2021;18(1):284. 10.3390/ijerph18010284 33401657 PMC7794913 

  33. Ziegler CGK, Allon SJ, Nyquist SK, Mbano IM, Miao VN, Tzouanas CN, et al. SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues. Cell 2020;181(5):1016-35. 10.1016/j.cell.2020.04.035 32413319 PMC7252096 

  34. 10.1016/j.antiviral.2020.104759 Sigrist CJA, Bridge A, Le Mercier P. A potential role for integrins in host cell entry by SARS-CoV-2. Antiviral Res 2020;177:104759. 10.1016/j.antiviral.2020.104759 32130973 PMC7114098 

  35. 10.1038/nrendo.2015.205 Davis PJ, Goglia F, Leonard JL. Nongenomic actions of thyroid hormone. Nat Rev Endocrinol 2016;12(2):111-21. 10.1038/nrendo.2015.205 26668118 

  36. 10.1016/j.meegid.2021.104773 Bakhshandeh B, Sorboni SG, Javanmard AR, Mottaghi SS, Mehrabi M, Sorouri F. Variants in ACE2; potential influences on virus infection and COVID-19 severity. Infect Genet Evol 2021;90:104773. 10.1016/j.meegid.2021.104773 33607284 PMC7886638 

  37. 10.1530/EJE-20-0335 Lania A, Sandri MT, Cellini M, Mirani M, Lavezzi E, Mazziotti G. Thyrotoxicosis in patients with COVID-19: the THYRCOV study. Eur J Endocrinol 2020;183(4):381-7. 10.1530/EJE-20-0335 32698147 

  38. 10.1016/S2666-5247(20)30115-4 Hanley B, Naresh KN, Roufosse C, Nicholson AG, Weir J, Cooke GS, et al. Histopathological findings and viral tropism in UK patients with severe fatal COVID-19: a post-mortem study. Lancet Microbe 2020;1(6):e245-53. 10.1016/S2666-5247(20)30115-4 

  39. Yao XH, Ty L. Histopathological study of new coronavirus pneumonia (COVID-19) in three patients. Chin J Pathol 2020;49. 

  40. 10.1016/j.prp.2020.153097 Tabary M, Khanmohammadi S, Araghi F, Dadkhahfar S, Tavangar SM. Pathologic features of COVID-19: a concise review. Pathol Res Pract 2020;216(9):153097. 10.1016/j.prp.2020.153097 32825963 PMC7334952 

  41. 10.1016/S0140-6736(20)31305-2 Bradley BT, Maioli H, Johnston R, Chaudhry I, Fink SL, Xu H, et al. Histopathology and ultrastructural findings of fatal COVID-19 infections in Washington State: a case series. Lancet 2020;396(10247):320-32. 10.1016/S0140-6736(20)31305-2 

  42. Wang W, Ye YX, Yao H, Li H, Sun L, Wang A, et al. Evaluation and observation of serum thyroid hormone and parathyroid hormone in patients with severe acute respiratory syndrome. J Chin Antituberculous Assoc 2003;25:232-4. 

  43. 10.1016/j.humpath.2006.06.011 Wei L, Sun S, Xu C, Zhang J, Xu Y, Zhu H, et al. Pathology of the thyroid in severe acute respiratory syndrome. Hum Pathol 2007;38(1):95-102. 10.1016/j.humpath.2006.06.011 16996569 PMC7112059 

  44. 10.1056/NEJMra021194 Pearce EN, Farwell AP, Braverman LE. Thyroiditis. N Engl J Med 2003;348(26):2646-55. 10.1056/NEJMra021194 12826640 

  45. 10.1186/1743-422X-6-5 Desailloud R, Hober D. Viruses and thyroiditis: an update. Virol J 2009;6:5. 10.1186/1743-422X-6-5 19138419 PMC2654877 

  46. 10.1007/s40618-020-01311-8 Bellastella G, Maiorino MI, Esposito K. Endocrine complications of COVID-19: what happens to the thyroid and adrenal glands? J Endocrinol Invest 2020;43(8):1169-70. 10.1007/s40618-020-01311-8 32488724 PMC7265876 

  47. 10.1007/s42399-021-00912-5 Aemaz Ur Rehman M, Farooq H, Mohsin Ali M, Ebaad Ur Rehman M, Anwar Dar Q, Hussain A. The association of subacute thyroiditis with COVID-19: a systematic review. SN Compr Clin Med 2021:3:1515-1527. 10.1007/s42399-021-00912-5 33942028 PMC8082479 

  48. 10.1007/s40618-021-01506-7 Croce L, Gangemi D, Ancona G, Liboa F, Bendotti G, Minelli L, et al. The cytokine storm and thyroid hormone changes in COVID-19. J Endocrinol Invest 2021;44(5):891-904. 10.1007/s40618-021-01506-7 33559848 PMC7871522 

  49. 10.3389/fendo.2020.623792 Wang W, Su X, Ding Y, Fan W, Zhou W, Su J, et al. Thyroid function abnormalities in COVID-19 patients. Front Endocrinol 2021;11:623792. 10.3389/fendo.2020.623792 33679608 PMC7933556 

  50. 10.1507/endocrj.EJ20-0553 Mizuno S, Inaba H, Kobayashi K, Kubo K, Ito S, Hirobata T, et al. A case of postpartum thyroiditis following SARS-CoV-2 infection. Endocr J 2021;68(3):371-4. 10.1507/endocrj.EJ20-0553 33177251 

  51. 10.3389/fendo.2016.00120 Inaba H, De Groot LJ, Akamizu T. Thyrotropin receptor epitope and human leukocyte antigen in Graves’ disease. Front Endocrinol 2016;7:120. 10.3389/fendo.2016.00120 27602020 PMC4994058 

  52. 10.1111/tan.13941 Wang W, Zhang W, Zhang J, He J, Zhu F. Distribution of HLA allele frequencies in 82 Chinese individuals with coronavirus disease-2019 (Covid-19). HLA 2020;96(2):194-6. 10.1111/tan.13941 32424945 PMC7276866 

  53. 10.1111/tan.14047 Novelli A, Andreani M, Biancolella M, Liberatoscioli L, Passarelli C, Colona VL, et al. HLA allele frequencies and susceptibility to COVID-19 in a group of 99 Italian patients. HLA 2020;96(5):610-4. 10.1111/tan.14047 32827207 PMC7461491 

  54. 10.3389/fphar.2020.01093 Liu Z, Li J, Chen D, Gao R, Zeng W, Chen S, et al. Dynamic interleukin-6 level changes as a prognostic indicator in patients with COVID-19. Front Pharmacol 2020;11:1093. 10.3389/fphar.2020.01093 32765283 PMC7379481 

  55. 10.1016/j.ando.2020.09.001 Caron P. Thyroid disorders and SARS-CoV-2 infection: from pathophysiological mechanism to patient management. Ann Endocrinol 2020;81(5):507-10. 10.1016/j.ando.2020.09.001 32950466 PMC7498405 

  56. 10.3389/fimmu.2020.01708 Tang Y, Liu J, Zhang D, Xu Z, Ji J, Wen C. Cytokine storm in COVID-19: the current evidence and treatment strategies. Front Immunol 2020;11:1708. 10.3389/fimmu.2020.01708 32754163 PMC7365923 

  57. 10.1080/22221751.2020.1770129 Han H, Ma Q, Li C, Liu R, Zhao L, Wang W, et al. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors. Emerg Microbes Infect 2020;9(1):1123-30. 10.1080/22221751.2020.1770129 32475230 PMC7473317 

  58. 10.1210/endocr/bqab004 Chen W, Tian Y, Li Z, Zhu J, Wei T, Lei J. Potential interaction between SARS-CoV-2 and thyroid: a review. Endocrinology 2021;162(3):bqab004. 10.1210/endocr/bqab004 33543236 PMC7953946 

  59. 10.1016/j.dsx.2020.07.044 Hariyanto TI, Kurniawan A. Thyroid disease is associated with severe coronavirus disease 2019 (COVID-19) infection. Diabetes Metab Syndr Clin Res Rev 2020;14(5):1429-30. 10.1016/j.dsx.2020.07.044 32755846 PMC7387272 

  60. 10.1007/s40618-020-01366-7 Mateu-Salat M, Urgell E, Chico A. SARS-COV-2 as a trigger for autoimmune disease: report of two cases of Graves’ disease after COVID-19. J Endocrinol Invest 2020;43(10):1527-8. 10.1007/s40618-020-01366-7 32686042 PMC7368923 

  61. 10.1016/S2213-8587(20)30266-7 Muller I, Cannavaro D, Dazzi D, Covelli D, Mantovani G, Muscatello A, et al. SARS-CoV-2-related atypical thyroiditis. Lancet Diabetes Endocrinol 2020;8(9):739-41. 10.1016/S2213-8587(20)30266-7 

  62. 10.11622/smedj.2020106 Tee LY, Harjanto S, Rosario BH. COVID-19 complicated by Hashimoto’s thyroiditis. Singapore Med J 2021;62(5):265. 10.11622/smedj.2020106 32668831 

  63. 10.1159/000491388 Persani L, Brabant G, Dattani M, Bonomi M, Feldt-Rasmussen U, Fliers E, et al. 2018 European Thyroid Association (ETA) guidelines on the diagnosis and management of central hypothyroidism. Eur Thyroid J 2018;7(5):225-37. 10.1159/000491388 30374425 PMC6198777 

  64. 10.1089/thy.2020.0363 Chen M, Zhou W, Xu W. Thyroid function analysis in 50 patients with COVID-19: a retrospective study. Thyroid 2021; 31(1):8-11. 10.1089/thy.2020.0363 32600165 

  65. 10.1530/JOE-15-0133 de Vries EM, Fliers E, Boelen A. The molecular basis of the non-thyroidal illness syndrome. J Endocrinol 2015;225(3): R67-81. 10.1530/JOE-15-0133 25972358 

  66. 10.1089/thy.2014.0201 Van den Berghe G. Non-thyroidal illness in the ICU: a syndrome with different faces. Thyroid 2014;24(10):1456-65. 10.1089/thy.2014.0201 24845024 PMC4195234 

  67. 10.1186/s13063-020-04474-0 Pantos C, Kostopanagiotou G, Armaganidis A, Trikas A, Tseti I, Mourouzis I. Triiodothyronine for the treatment of critically ill patients with COVID-19 infection: a structured summary of a study protocol for a randomised controlled trial. Trials 2020;21(1):573. 10.1186/s13063-020-04474-0 32586399 PMC7316579 

  68. 10.1210/clinem/dgaa813 Lui DTW, Lee CH, Chow WS, Lee ACH, Tam AR, Fong CHY, et al. Thyroid dysfunction in relation to immune pro?le, disease status, and outcome in 191 patients with COVID-19. J Clin Endocrinol Metab 2021;106(2):e926-35. 10.1210/clinem/dgaa813 33141191 PMC7665541 

  69. 10.1210/clinem/dgaa830 Khoo B, Tan T, Clarke SA, Mills EG, Patel B, Modi M, et al. Thyroid function before, during and after COVID-19. J Clin Endocrinol Metab 2021;106(2):e803-11. 10.1210/clinem/dgaa830 33180932 PMC7823247 

  70. 10.1152/ajpendo.00480.2020 Kothandaraman N, Rengaraj A, Xue B, Yew WS, Velan SS, Karnani N, et al. COVID-19 endocrinopathy with hindsight from SARS. Am J Physiol Endocrinol Metab 2021;320(1): E139-50. 10.1152/ajpendo.00480.2020 33236920 PMC7816429 

  71. 10.3389/fendo.2020.00565 van Gerwen M, Alsen M, Little C, Barlow J, Naymagon L, Tremblay D, et al. Outcomes of patients with hypothyroidism and COVID-19: a retrospective cohort study. Front Endocrinol 2020;11:565. 10.3389/fendo.2020.00565 33013686 PMC7461836 

  72. 10.1158/2159-8290.CD-20-0422 Dai M, Liu D, Liu M, Zhou F, Li G, Chen Z, et al. Patients with cancer appear more vulnerable to SARS-CoV-2: a multicenter study during the COVID-19 outbreak. Cancer Discov 2020;10(6):783-91. 10.1158/2159-8290.CD-20-0422 32345594 PMC7309152 

  73. Kuderer NM, Choueiri TK, Shah DP, Shyr Y, Rubinstein SM, Rivera DR, et al. COVID-19 and Cancer Consortium. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet 2020;395(10241):1907-18. 10.1016/S0140-6736(20)31187-9 

  74. 10.1007/s12020-020-02439-6 Smulever A, Abelleira E, Bueno F, Pitoia F. Thyroid cancer in the Era of COVID-19. Endocrine 2020;70(1):1-5. 10.1007/s12020-020-02439-6 32754886 PMC7402074 

  75. 10.1016/j.ijrobp.2020.03.007 Filippi AR, Russi E, Magrini SM, Corvo R. Covid-19 outbreak in northern Italy: ?rst practical indications for radiotherapy departments. Int J Radiat Oncol Biol Phys 2020; 107(3):597-9. 10.1016/j.ijrobp.2020.03.007 32199941 PMC7141469 

  76. 10.1530/EJE-20-0445 Boelaert K, Visser WE, Taylor PN, Moran C, Leger J, Persani L. Endocrinology in the time of COVID-19: management of hyperthyroidism and hypothyroidism. Eur J Endocrinol 2020;183(1):G33-9. 10.1530/EJE-20-0445 32438340 PMC7938012 

관련 콘텐츠

오픈액세스(OA) 유형

GOLD

오픈액세스 학술지에 출판된 논문

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로